0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
PharmEasy’s revenue from operations shrank 14.8% to Rs 5,664 crore in FY24 as compared to Rs 6,644 crore in FY23, the firm controlled its losses by 51.4% to Rs 2,533.5 crore in FY24 in contrast to Rs 5,211.7 crore in FY23.
Share this article
If you liked this article share it with your friends.they will thank you later
/entrackr/media/media_files/2024/11/20/97EsyihAbX95Vo8IPOfW.png)
2 Min read
/entrackr/media/media_files/2024/11/20/apple-india.jpg)
/entrackr/media/media_files/2024/11/18/dezerv.png)
/entrackr/media/media_files/2024/11/19/tRWrKlkNAZ0ViE9eWFxH.jpg)
/entrackr/media/media_files/2024/11/18/5eLvQYGJXRAtD261DrIx.jpg)
/entrackr/media/media_files/2024/11/15/burger-singh.png)
/entrackr/media/media_files/2024/11/14/a2sdKgoJEjIG6SpdTezc.png)
/entrackr/media/media_files/2024/11/13/AYfeCHgf0mO99HEjLbC9.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2024/05/Nykaa-image-.jpg)
/entrackr/media/media_files/2024/11/12/9jeYaK9p0zDZMAihU2sg.png)
/entrackr/media/agency_attachments/2024/10/18/XDGqYgwk8PhvKwQWyFWY.png)
